文献速递腹部泌尿生殖CT

计算机辅助报告与决策支持提高肾上腺偶发瘤随访影像和激素筛查的依从性

Computer-assisted Reporting and Decision Support Increases Compliance with Follow-up Imaging and Hormonal Screening of Adrenal Incidentalomas.
PubMed 文献 · Acad Radiol · 2021-02-12

该回顾性研究纳入174例腹部CT报告描述肾上腺偶发瘤的患者,比较计算机辅助报告与决策支持(CAR/DS)报告与传统报告对开单医生遵循指南推荐进行随访影像(FUI)和激素筛查的影响。CAR/DS使用是开单医生遵循FUI(OR=2.47,p=0.02)和激素筛查(OR=2.38,p=0.04)的独立预测因子,且CAR/DS报告更常给出指南推荐的FUI和激素筛查建议。

要点

  • CAR/DS报告使开单医生遵循FUI建议的几率提高约2.47倍,遵循激素筛查建议的几率提高约2.38倍。
  • CAR/DS报告推荐FUI的比例为97.2%(105/108),显著高于传统报告的69.7%(46/66)。
  • CAR/DS报告推荐激素筛查的比例为87.0%(94/108),显著高于传统报告的3.0%(2/66)。

核心结论

  • 使用CAR/DS生成报告的开单医生对肾上腺偶发瘤FUI和激素评估建议的依从性至少是传统报告的两倍。
  • CAR/DS指导的建议比未使用CAR/DS生成的建议更符合指南。

研究设计与样本

  • 回顾性研究,从放射学数据库提取2014年至2016年描述肾上腺偶发瘤的腹部CT报告,共纳入174例患者(平均年龄62.4岁,女性51.1%)。
  • 排除标准为癌症病史、疑似功能性肾上腺肿瘤、优势结节大小<1 cm或≥4 cm、髓脂肪瘤、囊肿和血肿。
  • 采用多变量逻辑回归模型预测FUI和激素筛查医嘱与患者年龄、性别、结节大小及CAR/DS使用的关系。
  • 使用卡方检验比较CAR/DS报告与传统报告在开单医生依从性、频率及指南推荐完整性方面的差异。

诊断标准与关键数值

  • CAR/DS使用是开单医生遵循FUI的独立预测因子(OR=2.47,p=0.02)。
  • CAR/DS使用是开单医生遵循激素筛查的独立预测因子(OR=2.38,p=0.04)。
  • CAR/DS报告推荐FUI的比例为97.2%(105/108),传统报告为69.7%(46/66),p<0.0001。
  • CAR/DS报告推荐激素筛查的比例为87.0%(94/108),传统报告为3.0%(2/66),p<0.0001。
  • CAR/DS建议更常包含FUI时间、方案和检查方式的说明,与传统报告相比差异均有统计学意义(均p<0.001)。

临床应用与阅片要点

  • 在报告肾上腺偶发瘤时,使用CAR/DS工具可提高开单医生对FUI和激素筛查建议的依从性。
  • CAR/DS报告更常明确FUI的时间、方案和检查方式,有助于规范随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the impact of using a computer-assisted reporting and decision support (CAR/DS) tool at the radiologist point-of-care on ordering provider compliance with recommendations for adrenal incidentaloma workup.

METHOD: Abdominal CT reports describing adrenal incidentalomas (2014 - 2016) were retrospectively extracted from the radiology database. Exclusion criteria were history of cancer, suspected functioning adrenal tumor, dominant nodule size < 1 cm or ≥ 4 cm, myelolipomas, cysts, and hematomas. Multivariable logistic regression models were employed to predict follow-up imaging (FUI) and hormonal screening orders as a function of patient age and sex, nodule size, and CAR/DS use. CAR/DS reports were compared to conventional reports regarding ordering provider compliance with, frequency, and completeness of, guideline-warranted recommendations for FUI and hormonal screening of adrenal incidentalomas using Chi-square test.

RESULT: Of 174 patients (mean age 62.4; 51.1% women) with adrenal incidentalomas, 62% (108/174) received CAR/DS-based recommendations versus 38% (66/174) unassisted recommendations. CAR/DS use was an independent predictor of provider compliance both with FUI (Odds Ratio [OR]=2.47, p = 0.02) and hormonal screening (OR=2.38, p = 0.04). CAR/DS reports recommended FUI (97.2%,105/108) and hormonal screening (87.0%,94/108) more often than conventional reports (respectively, 69.7% [46/66], 3.0% [2/66], both p <0.0001). CAR/DS recommendations more frequently included instructions for FUI time, protocol, and modality than conventional reports (all p <0.001).

CONCLUSION: Ordering providers were at least twice as likely to comply with report recommendations for FUI and hormonal evaluation of adrenal incidentalomas generated using CAR/DS versus unassisted reporting. CAR/DS-directed recommendations were more adherent to guidelines than those generated without.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Almeida RR, Bizzo BC, Singh R, et al. Computer-assisted Reporting and Decision Support Increases Compliance with Follow-up Imaging and Hormonal Screening of Adrenal Incidentalomas. Acad Radiol. 2021. PMID: 33583714. doi:10.1016/j.acra.2021.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。